10x Genomics, Inc.

NASDAQ:TXG

Medical - Healthcare Information Services

Healthcare
$57.07 +7.75%

+$2.49 today

Market cap
$6.93B
Beta
2.11
P/E (TTM)
-196.0
EPS (TTM)
-$0.18
52W Low $10.48High $35.65

Volume 2.10M

Average 3.06M

TXG Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

10x Genomics, Inc.NASDAQ: TXG

Weighted Avg Shares · Q3 FY2026 · quarter ended Sep 2026

Weighted avg shares grows in line with its trailing trend

Q3 FY2026 weighted avg shares of 130.81M shares rose 4.2% year over year, in line with the +4.6% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +3.1% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +4.2% toward the trailing-twelve-month pace of +4.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
130.81M+0.6% QoQ
Last fiscal yearDec 2025
124.75M+3.6% YoY
LTMSep 2026
129.04M+4.6% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.2%——
1 year+3.6%——
3-year CAGR+3.1%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
124.75M USD
Year-over-year change
+3.6%
4-year CAGR
+3.1%

Weighted Avg Shares vs competitors

How TXG compares with its peers on the latest reported figures

  • TXG's LTM Sep 2026 weighted avg shares of 129.04M shares is the 6th highest of the 9 companies compared; the peer median is 154.31M shares.
  • Its year-over-year change of +4.6% is the highest of 9, against a peer median of -2.2%.
  • Over three fiscal years its annual growth of +3.1% compares with a peer median of -1.1%.
TXG Competitors Peer median
Weighted Avg Shares for TXG and competitors
Company Period LTM YoY 3-year CAGR
LABStandard BioTools Inc.LTM Mar 2026384.09M +2.7%+69.5%
AAgilent Technologies, Inc.LTM Jul 2026282.75M -1.2%-1.8%
QGENQiagen N.V.LTM Jun 2026209.5M -4.1%-2.0%
TECHBio-Techne CorporationLTM Sep 2026156.12M -0.3%-0.3%
ILMNIllumina, Inc.LTM Jun 2026152.5M -3.8%-0.4%
TXG10x Genomics, Inc.LTM Sep 2026129.04M +4.6%+3.1%
RVTYRevvity, Inc.LTM Jul 2026113.64M -5.7%-3.5%
TWSTTwist Bioscience CorporationLTM Sep 202661.95M +3.6%+3.3%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.9M -3.2%-2.9%
Peer median (excluding TXG) 154.31M-2.2%-1.1%

Competitors are the stored peer set for TXG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue490.49M516.41M618.73M610.79M642.82M
Cost of Revenue74.09M120.39M209.41M196.3M198.94M
Gross Profit416.4M396.02M409.31M414.48M443.88M
Gross Margin84.9%76.7%66.2%67.9%69.1%
Research & Development211.75M265.67M270.33M264.7M238.63M
Selling, General & Admin257.56M298.3M343.33M344.34M316.13M
Operating Expenses469.31M563.97M674.64M609.04M554.77M
Depreciation & Amortization28.25M33.01M43.62M43.71M43.82M
EBITDA(24.6M)(128.49M)(205.11M)(133.99M)3.91M
EBITDA Margin-5.0%-24.9%-33.2%-21.9%0.6%
Operating Income(52.91M)(167.94M)(265.33M)(194.56M)(110.89M)
Operating Margin-10.8%-32.5%-42.9%-31.9%-17.2%
Interest Income206K6.65M16.91M18.45M20.05M
Interest Expense866K476K33K4K0
Other Income / Expenses(802K)5.97M16.57M16.86M70.98M
Income Before Tax(53.72M)(161.97M)(248.76M)(177.7M)(39.91M)
Pre-Tax Margin-11.0%-31.4%-40.2%-29.1%-6.2%
Income Tax Expense4.51M4.03M6.34M4.93M3.64M
Net Income(58.22M)(166M)(255.1M)(182.63M)(43.54M)
Net Margin-11.9%-32.1%-41.2%-29.9%-6.8%
EPS (Basic)(0.53)(1.46)(2.18)(1.52)(0.35)
EPS (Diluted)(0.53)(1.46)(2.18)(1.52)(0.35)
Weighted Avg Shares110.35M113.86M117.17M120.45M124.75M
Weighted Avg Shares (Diluted)110.35M113.86M117.17M120.45M124.75M

10x Genomics, Inc.

NASDAQ:TXG

Intrinsic Alpha fair value

Locked

Current Price

$57.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.